J R Crouse 3rd
Overview
Explore the profile of J R Crouse 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters S, Lind L, Palmer M, Grobbee D, Crouse 3rd J, OLeary D, et al.
J Intern Med
. 2011 Dec;
272(3):257-66.
PMID: 22172243
Introduction: Echolucent plaques are related to a higher cardiovascular risk. Studies to investigate the relationship between echolucency and cardiovascular risk in the early stages of atherosclerosis are limited. We studied...
2.
Peters S, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, OLeary D, et al.
J Intern Med
. 2011 Jul;
271(3):247-56.
PMID: 21726301
Background: Automated edge detection is thought to be superior to manual edge detection in quantification of the far wall common carotid intima-media thickness (CIMT), yet published evidence making a direct...
3.
Peters S, Palmer M, Grobbee D, Crouse 3rd J, OLeary D, Raichlen J, et al.
J Intern Med
. 2010 Apr;
268(2):155-61.
PMID: 20412373
Objectives: In addition to its LDL-C-lowering effects, statin treatment reduces the level of C-reactive protein (CRP). Long-term data on this effect in low-risk populations are limited. Furthermore, whether the CRP...
4.
Bots M, Palmer M, Dogan S, Plantinga Y, Raichlen J, Evans G, et al.
J Intern Med
. 2009 Mar;
265(6):698-707.
PMID: 19298496
Background: In several statin trials, vascular event rates for treatment groups begin to separate 1 year after commencement of treatment. For atherosclerosis progression, the temporal sequence of the effect has...
5.
Herrington D, Espeland M, Crouse 3rd J, Robertson J, RILEY W, McBurnie M, et al.
Arterioscler Thromb Vasc Biol
. 2001 Dec;
21(12):1955-61.
PMID: 11742870
It remains unclear whether estrogen therapy (with or without progestin) improves endothelial function in older postmenopausal women with or at risk for coronary heart disease. To address this issue, we...
6.
Carr J, Danitschek J, Goff D, Crouse 3rd J, DAgostino R, Chen M, et al.
Int J Cardiovasc Imaging
. 2001 Oct;
17(3):213-20.
PMID: 11587455
Current generation Helical Computed Tomography, when coupled with cardiac gating can be used to measure coronary vascular calcium. In this article we review the development of retrospectively gated helical computed...
7.
Crouse 3rd J
Am J Cardiol
. 2001 Jul;
88(2A):27E-30E.
PMID: 11473742
Several pieces of evidence provide a rationale for an association between disease of the extracranial carotid arteries and incident coronary artery disease (CAD): (1) patients with transient ischemic attack are...
8.
Illingworth D, Crouse 3rd J, Hunninghake D, Davidson M, Escobar I, Stalenhoef A, et al.
Curr Med Res Opin
. 2001 Jul;
17(1):43-50.
PMID: 11464446
Objective: At higher doses, simvastatin has been shown to produce significantly greater increases in high-density lipoprotein (HDL) cholesterol and apolipoprotein (apo) A-I than atorvastatin. To extend and confirm these findings,...
9.
Crouse 3rd J, Furberg C
Arterioscler Thromb Vasc Biol
. 2000 Nov;
20(11):2333-5.
PMID: 11073834
No abstract available.
10.
Garg R, Elam M, Crouse 3rd J, Davis K, Kennedy J, Egan D, et al.
Am Heart J
. 2000 Oct;
140(5):792-803.
PMID: 11054628
Background: Patients with peripheral arterial disease (PAD) are at an increased risk of cardiovascular mortality and morbidity and thus are an excellent group in whom to evaluate the feasibility and...